世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034638

エピジェネティクスの世界市場(2023-2027)

TechNavio

Global Epigenetics Market 2023-2027

発刊日 2023/03/08

言語英語

体裁PDF/163ページ

ライセンス/価格163ページ

0000034638

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、エピジェネティクス市場を分析します。

世界のエピジェネティクス市場は、予測期間中に約14.06 %のCAGRで拡大し、2022年から2027年の間に11億4,820万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、非腫瘍性疾患におけるエピジェネティックの用途の増加、CVDの有病率の増加、戦略的提携やM&Aの増加によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 用途別
      ◇ 腫瘍学
      ◇ 非腫瘍学
    ➣ 製品別
      ◇ 試薬
      ◇ キット
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ アジア
      ◇ ヨーロッパ
      ◇ その他の地域

本調査では、今後数年間におけるエピジェネティクス市場の成長を促進する主要な理由の一つとして、ライフサイエンス産業における技術的進歩を挙げています。また、ゲノムプロジェクトの増加や最近の開発件数の増加は、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • エピジェネティクスの市場規模
  • エピジェネティクスの市場予測
  • エピジェネティクス市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なエピジェネティクス市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Abcam plc
    ➣ Active Motif Inc.
    ➣ Agilent Technologies Inc.
    ➣ Bio Rad Laboratories Inc.
    ➣ Bio Techne Corp.
    ➣ BioVision Inc.
    ➣ CellCentric Ltd.
    ➣ Enzo Biochem Inc.
    ➣ EpiGentek Group Inc.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Hologic Inc
    ➣ Illumina Inc.
    ➣ Merck KGaA
    ➣ New England Biolabs Inc.
    ➣ Pacific Biosciences of California Inc.
    ➣ Perkin Elmer Inc.
    ➣ Promega Corp.
    ➣ QIAGEN NV
    ➣ Thermo Fisher Scientific Inc.
    ➣ Zymo Research Corp.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global epigenetics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global epigenetics market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2022-2027
Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
6.4 Non-oncology - Market size and forecast 2022-2027
Exhibit 38: Chart on Non-oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Non-oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Non-oncology - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Non-oncology - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product
7.1 Market segments
Exhibit 44: Chart on Product - Market share 2022-2027 (%)
Exhibit 45: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Reagents - Market size and forecast 2022-2027
Exhibit 48: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Reagents - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
7.4 Kits - Market size and forecast 2022-2027
Exhibit 52: Chart on Kits - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Kits - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Kits - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Kits - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abcam plc
Exhibit 111: Abcam plc - Overview
Exhibit 112: Abcam plc - Product / Service
Exhibit 113: Abcam plc - Key news
Exhibit 114: Abcam plc - Key offerings
12.4 Active Motif Inc.
Exhibit 115: Active Motif Inc. - Overview
Exhibit 116: Active Motif Inc. - Product / Service
Exhibit 117: Active Motif Inc. - Key offerings
12.5 Agilent Technologies Inc.
Exhibit 118: Agilent Technologies Inc. - Overview
Exhibit 119: Agilent Technologies Inc. - Business segments
Exhibit 120: Agilent Technologies Inc. - Key news
Exhibit 121: Agilent Technologies Inc. - Key offerings
Exhibit 122: Agilent Technologies Inc. - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 123: Bio Rad Laboratories Inc. - Overview
Exhibit 124: Bio Rad Laboratories Inc. - Business segments
Exhibit 125: Bio Rad Laboratories Inc. - Key news
Exhibit 126: Bio Rad Laboratories Inc. - Key offerings
Exhibit 127: Bio Rad Laboratories Inc. - Segment focus
12.7 BioVision Inc.
Exhibit 128: BioVision Inc. - Overview
Exhibit 129: BioVision Inc. - Product / Service
Exhibit 130: BioVision Inc. - Key offerings
12.8 EpiGentek Group Inc.
Exhibit 131: EpiGentek Group Inc. - Overview
Exhibit 132: EpiGentek Group Inc. - Product / Service
Exhibit 133: EpiGentek Group Inc. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Hologic Inc.
Exhibit 139: Hologic Inc. - Overview
Exhibit 140: Hologic Inc. - Business segments
Exhibit 141: Hologic Inc. - Key news
Exhibit 142: Hologic Inc. - Key offerings
Exhibit 143: Hologic Inc. - Segment focus
12.11 Illumina Inc.
Exhibit 144: Illumina Inc. - Overview
Exhibit 145: Illumina Inc. - Business segments
Exhibit 146: Illumina Inc. - Key news
Exhibit 147: Illumina Inc. - Key offerings
Exhibit 148: Illumina Inc. - Segment focus
12.12 Merck KGaA
Exhibit 149: Merck KGaA - Overview
Exhibit 150: Merck KGaA - Business segments
Exhibit 151: Merck KGaA - Key news
Exhibit 152: Merck KGaA - Key offerings
Exhibit 153: Merck KGaA - Segment focus
12.13 New England Biolabs Inc.
Exhibit 154: New England Biolabs Inc. - Overview
Exhibit 155: New England Biolabs Inc. - Product / Service
Exhibit 156: New England Biolabs Inc. - Key news
Exhibit 157: New England Biolabs Inc. - Key offerings
12.14 Perkin Elmer Inc.
Exhibit 158: Perkin Elmer Inc. - Overview
Exhibit 159: Perkin Elmer Inc. - Business segments
Exhibit 160: Perkin Elmer Inc. - Key news
Exhibit 161: Perkin Elmer Inc. - Key offerings
Exhibit 162: Perkin Elmer Inc. - Segment focus
12.15 QIAGEN NV
Exhibit 163: QIAGEN NV - Overview
Exhibit 164: QIAGEN NV - Product / Service
Exhibit 165: QIAGEN NV - Key news
Exhibit 166: QIAGEN NV - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 167: Thermo Fisher Scientific Inc. - Overview
Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
Exhibit 169: Thermo Fisher Scientific Inc. - Key news
Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
12.17 Zymo Research Corp.
Exhibit 172: Zymo Research Corp. - Overview
Exhibit 173: Zymo Research Corp. - Product / Service
Exhibit 174: Zymo Research Corp. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global epigenetics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Non-oncology - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Non-oncology - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Non-oncology - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Non-oncology - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Chart on Product - Market share 2022-2027 (%)
Exhibits45: Data Table on Product - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Reagents - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Kits - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Kits - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Kits - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Kits - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abcam plc - Overview
Exhibits112: Abcam plc - Product / Service
Exhibits113: Abcam plc - Key news
Exhibits114: Abcam plc - Key offerings
Exhibits115: Active Motif Inc. - Overview
Exhibits116: Active Motif Inc. - Product / Service
Exhibits117: Active Motif Inc. - Key offerings
Exhibits118: Agilent Technologies Inc. - Overview
Exhibits119: Agilent Technologies Inc. - Business segments
Exhibits120: Agilent Technologies Inc. - Key news
Exhibits121: Agilent Technologies Inc. - Key offerings
Exhibits122: Agilent Technologies Inc. - Segment focus
Exhibits123: Bio Rad Laboratories Inc. - Overview
Exhibits124: Bio Rad Laboratories Inc. - Business segments
Exhibits125: Bio Rad Laboratories Inc. - Key news
Exhibits126: Bio Rad Laboratories Inc. - Key offerings
Exhibits127: Bio Rad Laboratories Inc. - Segment focus
Exhibits128: BioVision Inc. - Overview
Exhibits129: BioVision Inc. - Product / Service
Exhibits130: BioVision Inc. - Key offerings
Exhibits131: EpiGentek Group Inc. - Overview
Exhibits132: EpiGentek Group Inc. - Product / Service
Exhibits133: EpiGentek Group Inc. - Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. - Overview
Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
Exhibits136: F. Hoffmann La Roche Ltd. - Key news
Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits139: Hologic Inc. - Overview
Exhibits140: Hologic Inc. - Business segments
Exhibits141: Hologic Inc. - Key news
Exhibits142: Hologic Inc. - Key offerings
Exhibits143: Hologic Inc. - Segment focus
Exhibits144: Illumina Inc. - Overview
Exhibits145: Illumina Inc. - Business segments
Exhibits146: Illumina Inc. - Key news
Exhibits147: Illumina Inc. - Key offerings
Exhibits148: Illumina Inc. - Segment focus
Exhibits149: Merck KGaA - Overview
Exhibits150: Merck KGaA - Business segments
Exhibits151: Merck KGaA - Key news
Exhibits152: Merck KGaA - Key offerings
Exhibits153: Merck KGaA - Segment focus
Exhibits154: New England Biolabs Inc. - Overview
Exhibits155: New England Biolabs Inc. - Product / Service
Exhibits156: New England Biolabs Inc. - Key news
Exhibits157: New England Biolabs Inc. - Key offerings
Exhibits158: Perkin Elmer Inc. - Overview
Exhibits159: Perkin Elmer Inc. - Business segments
Exhibits160: Perkin Elmer Inc. - Key news
Exhibits161: Perkin Elmer Inc. - Key offerings
Exhibits162: Perkin Elmer Inc. - Segment focus
Exhibits163: QIAGEN NV - Overview
Exhibits164: QIAGEN NV - Product / Service
Exhibits165: QIAGEN NV - Key news
Exhibits166: QIAGEN NV - Key offerings
Exhibits167: Thermo Fisher Scientific Inc. - Overview
Exhibits168: Thermo Fisher Scientific Inc. - Business segments
Exhibits169: Thermo Fisher Scientific Inc. - Key news
Exhibits170: Thermo Fisher Scientific Inc. - Key offerings
Exhibits171: Thermo Fisher Scientific Inc. - Segment focus
Exhibits172: Zymo Research Corp. - Overview
Exhibits173: Zymo Research Corp. - Product / Service
Exhibits174: Zymo Research Corp. - Key offerings
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations

この商品のレポートナンバー

0000034638

TOP